﻿<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	「美国药监局授予脊髓损伤新药突破认定」的评论	</title>
	<atom:link href="https://finsage.org/2026/11/13/%E7%BE%8E%E5%9B%BD%E8%8D%AF%E7%9B%91%E5%B1%80%E6%8E%88%E4%BA%88%E8%84%8A%E9%AB%93%E6%8D%9F%E4%BC%A4%E6%96%B0%E8%8D%AF%E7%AA%81%E7%A0%B4%E8%AE%A4%E5%AE%9A/feed/" rel="self" type="application/rss+xml" />
	<link>https://finsage.org/2026/11/13/%e7%be%8e%e5%9b%bd%e8%8d%af%e7%9b%91%e5%b1%80%e6%8e%88%e4%ba%88%e8%84%8a%e9%ab%93%e6%8d%9f%e4%bc%a4%e6%96%b0%e8%8d%af%e7%aa%81%e7%a0%b4%e8%ae%a4%e5%ae%9a/</link>
	<description>专注严肃财经研判，陪伴清醒的商业决策者。</description>
	<lastBuildDate>Thu, 12 Nov 2026 22:32:37 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
</channel>
</rss>
